Archives mensuelles : septembre 2013

Accueil/2013/septembre

Pre-clinical proof-of-concept studies exploring schedules of administration of an adenovirus-based HBV immunotherapeutic show wide potential for induction of robust and long-lasting T-cell responses.

Houda Boukhebza, et al. Journal of Hepatology, 2013, (58), Supplement [...]

Par |2019-07-03T12:11:29+02:00septembre 3rd, 2013|Publication, TG1050|Commentaires fermés sur Pre-clinical proof-of-concept studies exploring schedules of administration of an adenovirus-based HBV immunotherapeutic show wide potential for induction of robust and long-lasting T-cell responses.

130 – A multivalent adenovirus-based immunotherapeutic for treatment of chronic hepatitis B induces broad, robust and polyfunctional T cells in naive and HBV tolerant mice.

Perrine Martin, et al. Journal of Hepatology, 2013, (58), Supplement [...]

Par |2019-07-03T12:16:48+02:00septembre 2nd, 2013|Publication, TG1050|Commentaires fermés sur 130 – A multivalent adenovirus-based immunotherapeutic for treatment of chronic hepatitis B induces broad, robust and polyfunctional T cells in naive and HBV tolerant mice.
Go to Top